HGH Replacement Therapy and Bone Density
The calcium is what our bones are made of. It is the calcium that provides it thickness and strength. With the increasing age, the bones in our bodies get weak and brittle. The primary reason for that is the inability of the body in absorbing and depositing the sufficient amount of calcium required by the bones. The reduction in calcium leads to it becoming thin, light and more porous and thus increases the probability of developing fractures and injuries. The HGH has been identified as being of particular importance when it comes to sustaining growth and good bone density. Past the age of 30, the production of HGH in our bodies reduces significantly and thus increases the risk of osteoporosis- the bone conditions where they are severely brittle and weak. Apart from just the reduction in the ability of absorbing calcium and age, other factors like genetics (race and family history), nutrition factors (balanced diet), regular and sufficient exercise and hormonal changes (women after menopause develop a higher risk of osteoporosis due to alterations in hormonal profile) also contribute towards the bone density and its strength in human beings.
Osteoporosis is a major medical condition associated primarily with the elderly. It is a condition where the bone density is severely reduced and leads them to being much lighter, brittle and thus more prone to fractures. The fractures to the elderly, apart from being painful and affecting mobility, can even be life threatening. The fractured hip can cause damage to the femoral artery that supplies blood to the lower extremity of the body. The damaged femoral artery may lead to death due to hemorrhage in the elderly, and this makes the role of HGH all the more important, as it can help maintaining a higher bone density and prevent such fatalities.
How HGH helps in maintaining a healthy bone density
Many researches have been undertaken to establish the relationship between the HGH and bone density. In simpler terms, the relationship between HGH and bone density can be explained through IGF-1 (insulin like growth factor-1). The IGF-1 is produced in liver after the stimulation by HGH produced in pituitary gland. The IGF-1 regulates the metabolism in the body and increases the synthesis of proteins in the body. This results in the increase in the requirement of proteins and other nutrients which are absorbed through the gastro intestinal system. The proteins have been associated with the ability to regulate absorption of calcium into the blood stream. This has been corroborated by the fact that a high protein diet has been scientifically proven to enhance the absorption of calcium in the body. The higher intake of calcium means the higher concentration of it being absorbed by the bones, and thus results in them being stronger and thicker. Thus HGH works by increasing the demand of proteins which then enhances the calcium absorption.
HGH therapy and healthy bones
Many studies in hormone therapy link it with the well being of bones. One such remarkable study was published in the Journal of Clinical Endocrinology and Metabolism (JCEM). It was found that the ending of hormone therapy treatment in elderly women resulted in a reduction in the bone mineral density among the 500 women belonging to the age group of 65 to 77 years. The subjects were analyzed for an interval of three years and the test was double blind, placebo controlled randomized clinical trial. Other two similar studies in this field looked at the recombinant Human Growth Hormone (HGH) for the treatment of osteoporosis in men and Dehydroepiandrosterone (DHEA) in the management of osteoporosis in young women. From the three researches it can be concluded that the risk of rapid bone loss increases with discontinuation of hormone replacement treatment for two years or more. The first year after stopping the treatment saw the maximum amount of bone loss, a drop in the calcium absorption and an increase in serum PTH levels.